Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-22-018298

Options or other derivatives

  • Chief R&D Officer acquired 475,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cavanagh William Chief R&D Officer 2022-07-21 Grant or award · Stock Options (right to buy) +475,000 1,493,846 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…